Zobrazeno 1 - 10
of 22
pro vyhledávání: '"M A, Noordzij"'
Autor:
Hilda A. de Barros, Jan J. Duin, Daan Mulder, Vincent van der Noort, M. Arjen Noordzij, Esther M.K. Wit, Floris J. Pos, Wouter V. Vogel, Eva E. Schaake, Fijs W.B. van Leeuwen, Pim J. van Leeuwen, Nikolaos Grivas, Henk G. van der Poel
Publikováno v:
European Urology Open Science, Vol 49, Iss , Pp 80-89 (2023)
Background: Accurate identification of men who harbor nodal metastases is necessary to select patients who most likely benefit from whole pelvis radiotherapy (WPRT). Limited sensitivity of diagnostic imaging approaches for the detection of nodal micr
Externí odkaz:
https://doaj.org/article/f9255bdaee584a7bb5c56c0bf65545d6
Autor:
Marinus J. Hagens, M. Arjen Noordzij, Jan Willem Mazel, Auke Jager, Thierry N. Boellaard, Jeroen A.W. Tielbeek, Margot Henebiens, Ivo G. Schoots, Pim J. van Leeuwen, Henk G. van der Poel, Sybren P. Rynja
Publikováno v:
European Urology Open Science, Vol 43, Iss , Pp 68-73 (2022)
Background: Considering that most men benefit diagnostically from increased sampling of index lesions, limiting systematic biopsy (SBx) to the region around the index lesion could potentially minimize overdetection while maintaining the detection of
Externí odkaz:
https://doaj.org/article/5e5c60038657464e85253be1f3d30026
Autor:
Rja Oomen, Joost L. Boormans, P J Ausems, S D Bos, Henk G. van der Poel, Henk B. Luiting, André N. Vis, Deric K E van der Schoot, Katja K.H. Aben, L Korsten, M A Noordzij, A van der West, T. van Doeveren, K J Lentjes, B P Schrier, P J Stelwagen, E L Koldewijn, M M Hobijn, Sytse C. van Beek, N van Ginkel, D M Somford, K T Buddingh, B.P. Wijsman, P van Zanten, Jakko A. Nieuwenhuijzen, H Bickerstaffe, K Dekker, M Braam, S Claus, S van der Meer, R I Nooter, O S Klaver, Jgh van Roermund, Smh Einerhand, A Lenting, Cpam Berger, M Jaspers-Valentijn, LA Grondhuis Palacios, D Baselmans, Tjn Hermans, H Roshani, T J Arends, Florentien J Hinsenveld, Ama Stroux, Caw Notenboom, M A van der Slot, A Berrens, J de Rooij, E J van Gennep, Lmcl Fossion, S H van Huystee, Wakm Windt
Publikováno v:
Urologic Oncology-Seminars and Original Investigations, 40, 60.e1-60.e9
Urologic Oncology: Seminars and Original Investigations. Elsevier Inc.
Urologic oncology-seminars and Original Investigations, 40(2), 60.e1-60.e9. Elsevier Science
Hinsenveld, F J, Boormans, J L, van der Poel, H G, van der Schoot, D K E, Vis, A N, Aben, K K H, Arends, T J, Ausems, P J, Baselmans, D, Berger, C P A M, Berrens, A, Bickerstaffe, H, Bos, S D, Braam, M, Buddingh, K T, Claus, S, Dekker, K, van Doeveren, T, Einerhand, S M H, Fossion, L M C L, van Gennep, E J, van Ginkel, N, Palacios, L A G, Hermans, T J N, Hobijn, M M, van Huystee, S H, Jaspers-Valentijn, M, Klaver, O S, Koldewijn, E L, On behalf of the Dutch Cystectomy Snapshot Group, Korsten, L, Lenting, A, Lentjes, K J, Luiting, H B, van der Meer, S, Nieuwenhuijzen, J A, Noordzij, M A, Nooter, R I, Notenboom, C A W, Oomen, R J A, van Roermund, J G H, de Rooij, J, Roshani, H, Schrier, B P, van der Slot, M A, Somford, D M, Stelwagen, P J, Stroux, A M A, van der West, A, Wijsman, B P, Windt, W A K M, van Zanten, P & van Beek, S C 2021, ' Intermediate-term survival of robot-assisted versus open radical cystectomy for muscle-invasive and high-risk non-muscle invasive bladder cancer in The Netherlands ', Urologic Oncology: Seminars and Original Investigations . https://doi.org/10.1016/j.urolonc.2021.06.018
Urologic Oncology-Seminars and Original Investigations, 40, 2, pp. 60.e1-60.e9
Urologic Oncology: Seminars and Original Investigations, 40(2), 60.e1-60.e9. Elsevier Inc.
Urologic Oncology: Seminars and Original Investigations. Elsevier Inc.
Urologic oncology-seminars and Original Investigations, 40(2), 60.e1-60.e9. Elsevier Science
Hinsenveld, F J, Boormans, J L, van der Poel, H G, van der Schoot, D K E, Vis, A N, Aben, K K H, Arends, T J, Ausems, P J, Baselmans, D, Berger, C P A M, Berrens, A, Bickerstaffe, H, Bos, S D, Braam, M, Buddingh, K T, Claus, S, Dekker, K, van Doeveren, T, Einerhand, S M H, Fossion, L M C L, van Gennep, E J, van Ginkel, N, Palacios, L A G, Hermans, T J N, Hobijn, M M, van Huystee, S H, Jaspers-Valentijn, M, Klaver, O S, Koldewijn, E L, On behalf of the Dutch Cystectomy Snapshot Group, Korsten, L, Lenting, A, Lentjes, K J, Luiting, H B, van der Meer, S, Nieuwenhuijzen, J A, Noordzij, M A, Nooter, R I, Notenboom, C A W, Oomen, R J A, van Roermund, J G H, de Rooij, J, Roshani, H, Schrier, B P, van der Slot, M A, Somford, D M, Stelwagen, P J, Stroux, A M A, van der West, A, Wijsman, B P, Windt, W A K M, van Zanten, P & van Beek, S C 2021, ' Intermediate-term survival of robot-assisted versus open radical cystectomy for muscle-invasive and high-risk non-muscle invasive bladder cancer in The Netherlands ', Urologic Oncology: Seminars and Original Investigations . https://doi.org/10.1016/j.urolonc.2021.06.018
Urologic Oncology-Seminars and Original Investigations, 40, 2, pp. 60.e1-60.e9
Urologic Oncology: Seminars and Original Investigations, 40(2), 60.e1-60.e9. Elsevier Inc.
BACKGROUND: Radical cystectomy with pelvic lymph node dissection is the recommended treatment in non-metastatic muscle-invasive bladder cancer (MIBC). In randomised trials, robot-assisted radical cystectomy (RARC) showed non-inferior short-term oncol
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::271babd5374478c875b9eed3e1320aaf
https://doi.org/10.1016/j.urolonc.2021.06.018
https://doi.org/10.1016/j.urolonc.2021.06.018
Autor:
E. H. A. Hutten, M. W. Noordzij
Publikováno v:
MAB, Vol 73, Iss 9, Pp 461-466 (1999)
Externí odkaz:
https://doaj.org/article/acdc5442231e44e1a08b9e1e6f3a40f5
Autor:
J. Jager, M. Castro Cabezas, Joop D. Lefrandt, M. J. Noordzij, Andries J. Smit, P.H.N. Oomen, T. Brouwer, K. Yozgatli
Publikováno v:
Diabetic Medicine, 35(9), 1242-1248. Wiley
AIM The United Kingdom Prospective Diabetes Study (UKPDS) study showed that glycaemic control (HbA1c ) can predict vascular complications in Type 2 diabetes mellitus. The Diabetes Control and Complications Trial (DCCT) study showed that accumulation
Autor:
M. J. Noordzij, Johan Lefrandt, M. Castro Cabezas, T. Brouwer, P.H.N. Oomen, Douwe J. Mulder, Andries J. Smit, J. Jager
Publikováno v:
Diabetic Medicine. 29:1556-1561
AIMS: Skin autofluorescence is a non-invasive marker of advanced glycation end product accumulation. In a previous study, skin autofluorescence correlated with and predicted micro- and macrovascular complications in Type 2 diabetes in a primary care
Publikováno v:
Diabetes technology & therapeutics, 12(7), 581-585. MARY ANN LIEBERT, INC
Background: Accumulation of advanced glycation end products (AGEs) is accelerated during glycemic and oxidative stress and is an important predictor of complications in diabetes mellitus (DM).Study Design: Here we both review and present original dat
Autor:
Marco H. Blanker, M. Arjen Noordzij
Publikováno v:
Journal of the National Cancer Institute, 107(6):110. Oxford University Press
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::979407aa174a43091043652623ea3930
https://research.rug.nl/en/publications/c2a4bf49-9716-4b8c-9bad-9153e564886f
https://research.rug.nl/en/publications/c2a4bf49-9716-4b8c-9bad-9153e564886f
Autor:
K. U. Köhrmann, E. Mogler-Drautz, Fritz H. Schröder, M. A. Noordzij, A. v. d. Gaast, H. Kupper, P. Gebreamlack, Gerald H. Mickisch
Publikováno v:
Journal of Cancer Research and Clinical Oncology. 121:R11-R16
Multidrug resistance (MDR) in a variety of human tumours such as renal cell carcinoma (RCC) is thought to be caused by expression of the MDR1 gene and may be reversed by applying modern chemosensitisers such as dexverapamil, which inhibit the MDR1 ge
Autor:
Andries J. Smit, Robin P. F. Dullaart, Pieter Willem Kamphuisen, Clark J. Zeebregts, Helen L. Lutgers, Joop D. Lefrandt, M. J. Noordzij, Lisanne C. de Vos, Douwe J. Mulder
Publikováno v:
Arteriosclerosis thrombosis and vascular biology, 33(1), 131-138. LIPPINCOTT WILLIAMS & WILKINS
Objective— Evidence for an important role of advanced glycation end products (AGEs) in the development of atherosclerosis and cardiovascular disease beyond diabetes mellitus and renal disease is growing. Skin autofluorescence (SAF) is a validated n